MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is 1.56 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,141,000 | -51.0% | 249,800 | -63.4% | 0.76% | -44.9% |
| Q4 2020 | $10,487,000 | +9.4% | 682,500 | 0.0% | 1.37% | -26.9% |
| Q3 2020 | $9,589,000 | -31.9% | 682,500 | 0.0% | 1.88% | -34.0% |
| Q2 2020 | $14,073,000 | +184.1% | 682,500 | +4.0% | 2.84% | +116.5% |
| Q1 2020 | $4,953,000 | – | 656,000 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
| Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
| PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
| Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
| Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
| Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
| Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
| Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
| Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |